Navigation Links
Host Jennifer Love Hewitt Joins SBE, The Abbey and Los Angeles Magazine for 'The Envelope Please,' Benefiting AIDS Project Los Angeles
Date:2/21/2008

Oscar(R) Viewing Party to Roll Out the Red Carpet in West Hollywood for

Hundreds of Expected Guests

LOS ANGELES, Feb. 21 /PRNewswire/ -- SBE's The Abbey, Los Angeles Magazine and special host Jennifer Love Hewitt have joined forces to raise much-needed funds and awareness for AIDS Project Los Angeles (APLA) through the 7th annual "The Envelope Please" Oscar(R) viewing party.

To be held at The Abbey in West Hollywood on Sunday, February 24th, "The Envelope Please" is a black-tie cocktail and dinner event that has raised more than $1.2 million for APLA through the years. This year's fundraiser is expected to draw more than 500 guests for cocktails and a sit-down dinner featuring a menu developed by The Abbey's chef Michael Brown for the special event.

"Despite all the uncertainty surrounding the strike and the Oscar(R) telecast, the importance of this annual event has never diminished for APLA and the people we serve," said Craig E. Thompson, executive director of APLA, which is now in its 25th year of operation. "This evening has become one of the top fundraisers of the year for our organization and we are more excited than ever to roll out the red carpet for all our friends and guests on Oscar(R) night."

"Gathering with friends to watch the Academy Awards is one of my favorite traditions, and I am honored to join APLA's supporters once again for a great evening at The Abbey," said Jennifer Love Hewitt, who has hosted the event for the past four years. "We are looking forward to a memorable event with entertainment, food, and friends, and most importantly, a chance to raise much-needed funds for an important organization."

"'The Envelope Please' has become one of our best events of the year," said David Cooley, founder of The Abbey. "It is an honor to help our friends at APLA host this magical evening, and we are very proud of how we've been able to help the event grow through the years."

For th
'/>"/>

SOURCE AIDS Project Los Angeles
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Jennifer Chmieleski Joins Psychemedics Corporation as Top Financial Officer
2. Jennifer Garner Puts Flu Shot in the Spotlight
3. Richard Greco Joins Mediware Board
4. Johnson & Johnson Campaign for Nursings Future Joins With AACN to Offer New Minority Nurse Faculty Scholars Program
5. Sean P. McLaughlin Joins Red Cross as Chief of Operations Support
6. Dr. Mahesh Ramachandran Joins Marianjoy Medical Group
7. Nick Childs Joins Grey New York as Director of Content Development
8. Psychemedics Corporation Joins Accenture in Co-Sponsoring Innovative Chief Talent Officer Book
9. David Ward Joins OrthoSynetics(TM) as Western Region Sales Manager
10. NASN Joins Partnership to Fight Chronic Disease
11. AstraZeneca Joins Local Walking Movement

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/29/2009)... form between brain cells almost immediately as an...shed this week in Nature . Led by researchers at ...y involved detailed observations of the rewiring p... learning. , The researchers studied mice as the...ed. They observed rapid growth of structures that ...
(Date:11/29/2009)...equals a $41,000 pay raise, researchers say , ...hological therapy may be much more effective at ma...a lottery prize, suggests an English study. , R...o provided information about their mental well-bei... $1,329 course of therapy was so significant that ...
(Date:11/29/2009)...care,s uncertain future and rising costs open the ...dable Acupuncture Scottsdale answers the call. , ...-- Affordable Acupuncture, LLC opened in Scottsdal...h enthusiasm and gratitude. Its increasing popular...ngs, need and cost. "As far as I’m con...
(Date:11/28/2009)...r change after 30-minute psychosocial intervention...hDay News) -- A program that gets persistent drunk...ngerous behavior may lead to significant and long-...new study included 184 men and women with two or m...andomly assigned to one of two interventions. The ...
(Date:11/27/2009)...wire-FirstCall/ -- GSI Group Inc. (Pink Sheets: GS...ology products and semiconductor systems, today an...areholders has been scheduled for Friday, April 30... be announced in due course. As previously announ...m Stephen Bershad, a holder of greater than ten pe...
Breaking Medicine News(10 mins):Health News:Study shows new brain connections form rapidly during motor learning 2Health News:Study shows new brain connections form rapidly during motor learning 3Health News:Psychotherapy Can Boost Happiness More Than Money: Study 2Health News:Affordable Acupuncture Greeted with Open Arms by Scottsdale and Phoenix Communities 2Health News:Drunk Drivers May Respond to Brief Motivational Interview 2Health News:GSI Group Calls Shareholders Meeting 2
...have launched a public awareness campaign warning ...ess-skilled non-physicians performing the procedur...going procedures like Botox injections, laser hair...n some cases. The American Society of Derma...
... lifestyles and environmental changes have caused ...e. They represent 17% of the childhood cancer case... between 1978 and 1997 in 15 European countries we... the age of 14. Majority of the childhood canc...
...d’, a new oral drug that is being developed for mu...he new study has suggests that the experimental dr...ts with relapsing multiple sclerosis. It was also ...patients with MS the first effective treatment in ...
... have more urinary problems than white men, but ar...ology study that was conducted on over 8,000 men h...ology journal BJU International, states that South... in Leicestershire, UK, were randomly selected fro...
...t medical trusts facing major losses to outsource ... one million pounds a year.// Around 60 speci...sourcing. Hospitals in Leeds are reported to be fa...have been fiercely criticised by union leaders, MP...
...gram developed by researchers now at the Universit...e used to study how individuals with sickle cell d...erited blood disorder.// The $2.9 million f...to educate them about pain management and provide ...
Other Medicine News:Health News:Campaign Against Cosmetic Surgeries Performed By Less-Skilled Non-physicians Launched 2Health News:17 percent rise in childhood cancer cases due to modern lifestyles 2Health News:An Experimental New Drug Might Be Effective In Treating MS 2Health News:South Asian Men Have More Urinary Problems Than White Men 2Health News:Leeds Hospitals to Outsource Medical Transcription Work to India 2Health News:Computer May Improve Pain Relief for Sickle Cell Patients 2
(Date:11/28/2009)... Siemens Healthcare redefines prod...(Total imaging matrix) technology and with its new...technologies are introduced in the new MAGNETOM &#...ra* 3T scanners at the 95th Scientific Assembly an...rth America (RSNA) from November 29 to December 3 ...
(Date:11/26/2009)...outh Africa, Nov. 26 The 2009 Fros...Award in the Generic Pharmaceutical Market is pres...(Logo: http://www.newscom.com/cgi-bin/prnh/200811...d, the following criteria were used to benchmark C... growth strategy and implementation, degree of inn...
(Date:11/25/2009)...ov. 25 Pharmasset, Inc. ...company committed to discovering, developing and c...ns, reported financial results for the fiscal year...harmasset held $58.4 million in cash, cash equival...Update and 2009 Highlights ,, RG7128 ,, ...
Breaking Medicine Technology:Siemens Introduces Its New Power Couple at RSNA 2009 2Siemens Introduces Its New Power Couple at RSNA 2009 3Siemens Introduces Its New Power Couple at RSNA 2009 4Siemens Introduces Its New Power Couple at RSNA 2009 5Siemens Introduces Its New Power Couple at RSNA 2009 6Siemens Introduces Its New Power Couple at RSNA 2009 7Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 2Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 3Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 4Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8Pharmasset Reports Fiscal Year End 2009 Financial Results 9Pharmasset Reports Fiscal Year End 2009 Financial Results 10Synthetech Announces Fiscal 2009 Results 47845 1Synthetech Announces Fiscal 2009 Results 47845 2Synthetech Announces Fiscal 2009 Results 47845 3Synthetech Announces Fiscal 2009 Results 47845 4Synthetech Announces Fiscal 2009 Results 47845 5Synthetech Announces Fiscal 2009 Results 47845 6Consumer Watchdog Praises Insurance Commissioner Poizner for Health Insurance Rescission Rules Pans Schwarzenegger Administration for Failure to Regu 47842 1Consumer Watchdog Praises Insurance Commissioner Poizner for Health Insurance Rescission Rules Pans Schwarzenegger Administration for Failure to Regu 47842 2Consumer Watchdog Praises Insurance Commissioner Poizner for Health Insurance Rescission Rules Pans Schwarzenegger Administration for Failure to Regu 47842 3Americas Future Now Straw Poll 3A Progressives See Health Care Reform With Public Option As Top Priority 47838 1Americas Future Now Straw Poll 3A Progressives See Health Care Reform With Public Option As Top Priority 47838 2
...s Phase 3 Plans with FDA, PRINCETON, N.J., Sept. ...t successfully completed two key clinical trials i... low-dose, once-weekly,contraceptive patch, which ... AG-200-15. The Phase 2b safety and efficacy study...n suppression, cycle control and safety. The,pharm...
...Sept. 3 A sub-analysis of,the TRITON-TIMI 38 clin...mpared with clopidogrel significantly reduced the ...t vs. 9.7 percent, p<0.0001), regardless,of wh...tery-opening,procedure known as percutaneous coron...neously during the longer-term maintenance phase. ...
Other Medicine Technology:Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 2Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 3Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 4Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 2Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 3Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 4Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 5Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 6
HDL Cholesterol (PEG)
Cholesterol/HDL
HDL-Cholesterol Direct Reagent
HDL Cholesterol
Medicine Products: